Efficacy of Dalbavancin and Telavancin in the Treatment of Acute Bacterial Skin and Skin Structure Infections

OBJECTIVES: Two glycopeptide analogues, such as dalbavancin and telavancin, with improved pharmacokinetic/pharmacodynamic parameters have been developed. These two glycopeptide analogues are approved by Food and Drug Administration (FDA) for treatment of various Gram-positive bacterial skin infectio...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Maedica (Bucur)
Autors principals: NADIPELLY, Jagan, RAGHUNATH, Pendru, KOTHAPALLI, Jyothinath
Format: Artigo
Idioma:Inglês
Publicat: Tarus Media 2018
Matèries:
Original Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6290182/
https://ncbi.nlm.nih.gov/pubmed/30568740
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.26574/maedica.2018.13.3.208
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars